Ardent Health Partners, INC

Ardent Health, Inc. disclosed details of a separation agreement with former CEO Martin J. Bonick, outlining severance benefits and restrictive covenants.

Ardent Health announced Dave Caspers as its new CEO, succeeding Martin J. Bonick, and reaffirmed its full-year 2026 Adjusted EBITDA guidance.

Ardent Health, Inc. held its Annual Meeting of Stockholders on May 20, 2026, where directors were elected, executive compensation was approved advisory, and auditors were ratified.

Ardent Health announced first quarter 2026 financial results, showing a 7.0% increase in total revenue and a 26.3% rise in Adjusted EBITDA, while reaffirming its full-year guidance.

Ardent Health, Inc. announced the departure of Ethan Chernin as President, Hospital Services, effective March 24, 2026, with severance benefits.

Ardent Health, Inc. announced its fourth quarter and full-year 2025 financial results, showing solid 2025 growth but issuing prudent 2026 guidance due to industry headwinds.

Ardent Health reported a decrease in total revenue for the three months ended June 30, 2026, driven by lower net patient service revenue per adjusted admission, while operating expenses increased significantly.

Ardent Health reports a 7.0% increase in total revenue for Q1 2026, driven by higher net patient service revenue per adjusted admission, despite a slight dip in overall admissions.

Ardent Health, Inc. reported a net loss of $23.48 million for Q3 2025, impacted by a $42.6 million revenue accounting estimate change and a $47.2 million increase in professional liability reserves.

Ardent Health, Inc. announced robust financial results for the second quarter and first half of 2025, driven by increased patient volumes and higher reimbursement rates, despite new regulatory challenges.

Ardent Health Partners' Q1 2025 revenue increased by 4% year-over-year, driven by a rise in adjusted admissions and net patient service revenue per adjusted admission.

Ardent Health Partners saw a 5.2% increase in total revenue for the third quarter of 2024, driven by higher admissions and net patient service revenue.

Ardent Health, Inc. reported a 6.0% revenue increase in 2025 but saw net income decline significantly due to surging professional liability costs and the impact of new federal healthcare legislation.

Ardent Health Partners demonstrates resilience with solid 2024 financial performance despite a significant cybersecurity incident, focusing on growth and operational efficiency.

Dave Caspers, CEO and President of Ardent Health, Inc., reported the acquisition of 103,653 shares of common stock on July 1, 2026.

Director Robert DeMichiei acquired 11,260 shares of Ardent Health, Inc. common stock for an average price of $8.73 per share.

Ardent Health, Inc. Chief Financial Officer Alfred Lumsdaine acquired 10,000 shares of common stock on June 5, 2026.

Peter J. Bulgarelli, a Director at Ardent Health, Inc., acquired 14,231 restricted stock units on April 1, 2026, as part of a compensation plan.

Director Ellen Havdala acquired 14,231 shares of Ardent Health, Inc. common stock on April 1, 2026, as part of a restricted stock unit grant.

R. Sotir Mark, Director and Chair of the Board at Ardent Health, Inc., acquired 14,231 shares of common stock on April 1, 2026.

Ardent Health, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for May 20, 2026, to elect directors and vote on executive compensation and auditor ratification.

Ardent Health Partners, Inc. has filed a definitive proxy statement with the SEC regarding its upcoming annual meeting.

Ardent Health Partners announces its 2025 Annual Meeting of Stockholders to be held on May 21, 2025, covering director elections, executive compensation, and auditor ratification.

Ardent Health Partners updates its S-1 registration statement, targeting a New York Stock Exchange listing under the symbol ARDT and offering 14.3 million shares.

Ardent Health Partners has filed an amendment to its Form S-1 registration statement with the SEC, primarily to include the form of underwriting agreement.

Ardent Health Partners, the fourth-largest privately held for-profit hospital operator in the US, has filed for an initial public offering on the New York Stock Exchange, aiming to capitalize on growth in mid-sized urban markets.

Ardent Health Partners, a leading for-profit hospital operator, has filed an S-1 registration statement for an initial public offering (IPO).